Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06561685
What this trial is testing

LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid TumorNon-small Cell Lung Cancer+1 more
Eli Lilly and Company 340
Testing effectiveness (Phase 2)Study completedNCT03997968
What this trial is testing

CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Who this might be right for
MalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more
Cyteir Therapeutics, Inc. 169
Testing effectiveness (Phase 2)UnknownNCT05332574
What this trial is testing

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

Who this might be right for
NSCLCOther Solid Tumors
Genor Biopharma Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT03798743
What this trial is testing

Phase II Study on Sintilimab Combined With Docetaxel for Chemotherapy Failure Advanced NSCLC: the SUCCESS Study

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06335355
What this trial is testing

A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd 401
Early research (Phase 1)Looking for participantsNCT06307925
What this trial is testing

A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
HC Biopharma Inc. 122
Testing effectiveness (Phase 2)Study completedNCT02073968
What this trial is testing

PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+4 more
Albert Einstein College of Medicine 35
Early research (Phase 1)Ended earlyNCT06491225
What this trial is testing

Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients With Advanced Lung Adenocarcinoma

Who this might be right for
Advanced Lung Adenocarcinoma；Adult
Grit Biotechnology 2
Testing effectiveness (Phase 2)Looking for participantsNCT06702826
What this trial is testing

Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain MetastasesStereotactic Radiation+1 more
Rongrong Zhou 20
Not applicableUnknownNCT05974007
What this trial is testing

Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 1,500
Testing effectiveness (Phase 2)Study completedNCT01220063
What this trial is testing

RSHF in Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Institut Cancerologie de l'Ouest 48
Early research (Phase 1)Study completedNCT01325558
What this trial is testing

ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Malignant NeoplasmMalignant Solid Tumour
Altor BioScience 30
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Not applicableLooking for participantsNCT03702309
What this trial is testing

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

Who this might be right for
CancerBreast CancerLung Cancer+15 more
University Health Network, Toronto 2,500
Not applicableActive Not RecruitingNCT05747443
What this trial is testing

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

Who this might be right for
Lung CancerLung Cancer Screening
Kaiser Permanente 1,837
Not applicableUnknownNCT04587258
What this trial is testing

Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island

Who this might be right for
Breast CancerColorectal CancerCovid19
Rhode Island Hospital 100
Not applicableNot Yet RecruitingNCT06117644
What this trial is testing

The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC

Who this might be right for
Non Small Cell Lung CancerEGFR Gene MutationNon Small Cell Lung Cancer Stage IIIA+1 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 30
Testing effectiveness (Phase 2)UnknownNCT04706949
What this trial is testing

Pyrotinib Combined With Pemetrexed Plus Carboplatin in the First-line Treatment

Who this might be right for
Lung Cancer, Non-small Cell
Fudan University 26
Not applicableStudy completedNCT00071344
What this trial is testing

Analysis of Brain Metastasis in Patients With Lung Cancer

Who this might be right for
Carcinoma, Non-Small -Cell Lung
National Institute of Neurological Disorders and Stroke (NINDS) 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704
What this trial is testing

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more
National Cancer Institute (NCI) 9
Next Page